- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alzex Neuropharma Inc (TRRI)
Alzex Neuropharma Inc stock price live, this page displays OTC TRRI stock exchange data. View the TRRI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alzex Neuropharma Inc real time stock price chart below.
What Is the Alzex Neuropharma Inc Stock Price Today?
The Alzex Neuropharma Inc stock price today is 0.071.
What Is the Stock Symbol for Alzex Neuropharma Inc?
The stock symbol for Alzex Neuropharma Inc is ""TRRI.""
What Stock Exchange Does Alzex Neuropharma Inc Trade On?
Alzex Neuropharma Inc is listed and trades on the OTC Markets stock exchange.
Is Alzex Neuropharma Inc a Good Stock to Buy?
Determining whether Alzex Neuropharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRRI quote. (ISIN: US89656L1035)
What Is the Alzex Neuropharma Inc Stock Price Today?
The Alzex Neuropharma Inc stock price today is 0.071.
What Is the Stock Symbol for Alzex Neuropharma Inc?
The stock symbol for Alzex Neuropharma Inc is ""TRRI.""
What Stock Exchange Does Alzex Neuropharma Inc Trade On?
Alzex Neuropharma Inc is listed and trades on the OTC Markets stock exchange.
Is Alzex Neuropharma Inc a Good Stock to Buy?
Determining whether Alzex Neuropharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRRI quote. (ISIN: US89656L1035)
OTC Markets
Currency in USD
0.071
0.000(0.00%)
Delayed Data·
Fair Value
An estimate of a Alzex Neuropharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.071
0.071
52 wk Range
0.001
0.303
TRRI Scorecard
Full Analysis
Stock generally trades with low price volatility
TRRI is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Alzex Neuropharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0710.071
52 wk Range
0.0010.303
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TRRI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Alzex Neuropharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Alzex Neuropharma Inc Company Profile
Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.
Compare TRRI to Peers and Sector
Metrics to compare | TRRI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −9.6x | 2.5x | |
PEG Ratio | 0.00 | −0.06 | 0.00 | |
Price/Book | 0.0x | 1.9x | 1.6x | |
Price / LTM Sales | 0.0x | 25.0x | 1.3x | |
Upside (Analyst Target) | 0.0% | 15.3% | 19.4% | |
Fair Value Upside | Unlock | −33.1% | 2.2% | Unlock |
Earnings
Latest Release
Nov 14, 2013
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Alzex Neuropharma Trade On?
Alzex Neuropharma is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Alzex Neuropharma?
The stock symbol for Alzex Neuropharma is "TRRI."
What Is the Alzex Neuropharma Market Cap?
As of today, Alzex Neuropharma market cap is 106.87K.
What Is Alzex Neuropharma's Earnings Per Share (TTM)?
The Alzex Neuropharma EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is TRRI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Alzex Neuropharma Stock Split?
Alzex Neuropharma has split 4 times.
How Many Employees Does Alzex Neuropharma Have?
Alzex Neuropharma has 11 employees.
What is the current trading status of Alzex Neuropharma (TRRI)?
As of 30 Jul 2025, Alzex Neuropharma (TRRI) is trading at a price of 0.07, with a previous close of 0.07. The stock has fluctuated within a day range of 0.07 to 0.07, while its 52-week range spans from 0.00 to 0.30.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.